Results 91 to 100 of about 895 (134)

Three‐month outcomes of ziv‐aflibercept in the treatment of diabetic macular oedema [PDF]

open access: yesActa Ophthalmologica, 2016
Mohammed, Ashraf   +4 more
openaire   +2 more sources

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G. [PDF]

open access: yesTarget Oncol
Matsumoto T   +21 more
europepmc   +1 more source

Treatment outcomes of ziv‐aflibercept for treatment‐naïve polypoidal choroidal vasculopathy [PDF]

open access: yesActa Ophthalmologica, 2017
Errol W. Chan   +6 more
openaire   +2 more sources

Comment on: Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion

open access: yesIndian Journal of Ophthalmology, 2015
Alok Sen   +3 more
doaj   +1 more source

374 A phase IB trial of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Howard Streicher   +9 more
doaj   +1 more source

Intraperitoneal ziv-aflibercept effectively manages refractory ascites in colorectal cancer patients. [PDF]

open access: yesOncotarget, 2017
Lu CS   +11 more
europepmc   +1 more source

CLINICAL AND ELECTROPHYSIOLOGICAL EVALUATION AFTER INTRAVITREAL ZIV-AFLIBERCEPT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION. [PDF]

open access: yesRetina, 2017
de Oliveira Dias JR   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy